Status:

COMPLETED

X-ray Fluoroscopy Fused With Computed Tomography (XFC) Technical Development

Lead Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Aortic Valve Stenosis

Eligibility:

All Genders

18+ years

Brief Summary

Background: * Computed tomography (CT) creates three-dimensional images based on X-ray imaging. CT is useful for determining treatment approaches for certain diseases, such as calcific aortic stenosi...

Detailed Description

We will collect cardiac computed tomography (CT) data from patients with aortic valve stenosis being considered for surgical or catheter treatment. These data will be analyzed along with medically-nec...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • SELECTION CRITERIA: PATHWAY FOR RESEARCH CT:
  • Adult patients age 18 years or older
  • Having calcific aortic stenosis being considered for surgical or catheter-based treatment, determined on physical examination or noninvasive imaging such as echocardiography
  • Undergoing diagnostic cardiac catheterization within 1 year
  • Able to provide informed consent
  • ALTERNATIVE SELECTION CRITERIA: PATHWAY FOR ANALYSIS OF MEDICAL DATA:
  • Adult patients age 18 years or older
  • Having calcific aortic stenosis being considered for surgical or catheter-based treatment, determined on physical examination or noninvasive imaging such as echocardiography
  • Undergoing diagnostic cardiac catheterization within 1 year
  • Having undergone cardiac CT for medical indications meeting the technical requirements of this protocol
  • Able to provide informed consent
  • EXCLUSION CRITERIA:
  • SELECTION CRITERIA: PATHWAY FOR RESEARCH CT:
  • Pregnant or lactating women
  • Decompensated heart failure (unable to lie flat during CT)
  • EXCLUSION CRITERIA FOR BETA ADRENERGIC BLOCKERS:
  • Advanced atrioventricular block (Mobitz Type II second degree or third degree atrioventricular heart block)
  • Asthma or chronic obstructive pulmonary disease (emphysema) currently treated with beta adrenergic agonists
  • EXCLUSION CRITERIA FOR IODINATED RADIOCONTRAST:
  • Severe kidney disease (MDRD estimated Glomerular Filtration Rate
  • \< 30mL/min/l.73m(2)).
  • Request of referring physician or surgeon not to administer iodinated radiocontrast
  • ALTERNATIVE SELECTION CRITERIA: PATHWAY FOR ANALYSIS OF MEDICAL DATA:
  • None

Exclusion

    Key Trial Info

    Start Date :

    August 6 2009

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    May 27 2010

    Estimated Enrollment :

    1 Patients enrolled

    Trial Details

    Trial ID

    NCT00965679

    Start Date

    August 6 2009

    End Date

    May 27 2010

    Last Update

    July 2 2017

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institutes of Health Clinical Center, 9000 Rockville Pike

    Bethesda, Maryland, United States, 20892